VAERS reports by lot

Moderna COVID-19 lot 057F22A: VAERS reports

229 VAERS reports list lot 057F22A as a Moderna COVID-19 vaccine, received between 2022-10-04 and 2024-10-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
229
Reports
12%
Marked serious
1
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)20229%
Gastrointestinal10515%
Respiratory9414%
Neurological8612%
Cardiac / Cardiovascular6910%
Injection-site / Local reaction375%
Musculoskeletal314%
Dermatological (non-injection-site)264%
Thrombotic / Hematological193%
Allergic / Anaphylactic112%
Autoimmune / Immune-mediated41%
Psychiatric / Neuropsychiatric41%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey46
Florida19
Michigan11
New York10
Missouri8
Ohio7
Pennsylvania7
Washington7
Alaska6
Montana5
Arizona5
California5

Reports by month received

2022-1047
2022-1137
2022-1259
2023-0119
2023-0211
2023-032
2023-0428
2023-056
2023-065
2023-073
2023-083
2023-093
2023-112
2023-121
2024-021
2024-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.